Patient Guide: Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 93 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT02842086
Status: ACTIVE_NOT_RECRUITING
Condition: Pre-Exposure Prophylaxis of HIV-1 Infection
Phase: PHASE3

Find a Study Location Near You

This study is available at 93 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Beverly Hills, California
  • Los Angeles, California
  • Los Angeles, California
  • • And 90 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily